Sheehan, Jonathan H.

EGFR Fusions as Novel Therapeutic Targets in Lung Cancer

Konduri, K., Gallant, J.-N., Chae, Y. K., Giles, F. J., Gitlitz, B. J., Gowen, K., Ichihara, E., Owonikoko, T. K., Peddareddigari, V., Ramalingam, S. S., et al. (2016) · Cancer Discovery

Lung Cancer Treatments and MutationsHER2/EGFR in Cancer Research

Cited by 144

The role of Bruton’s tyrosine kinase in autoimmunity and implications for therapy

Crofford, L. J., Nyhoff, L. E., Sheehan, J. H., & Kendall, P. L. (2016) · Expert Review of Clinical Immunology

T-cell and B-cell ImmunologyImmunodeficiency and Autoimmune Disorders

Cited by 142

Molecular mechanisms of catalytic inhibition for active site mutations in glucose-6-phosphatase catalytic subunit 1 linked to glycogen storage disease

Sinclair, M., Stein, R. A., Sheehan, J. H., Hawes, E. M., O’Brien, R. M., Tajkhorshid, E., & Claxton, D. P. (2023) · PNAS Nexus

Glycogen Storage Diseases and MyoclonusProtein Structure and Dynamics

Cited by 8

Integrative analysis of pathogenic variants in glucose-6-phosphatase based on an AlphaFold2 model

Sinclair, M., Stein, R. A., Sheehan, J. H., Hawes, E. M., O’Brien, R. M., Tajkhorshid, E., & Claxton, D. P. (2024) · PNAS Nexus

Glycogen Storage Diseases and MyoclonusProtein Structure and Dynamics

Cited by 8